Skip to content
akaturk Academic measurement
Search

Article detail · 2013 · article

Predictive value of troponins and simplified pulmonary embolism severity index in patients with normotensive pulmonary embolism

YÖKSİS OpenAlex Open access · gold Top 10%
Year2013
Citations45OpenAlex
Citations47Semantic Scholar · 1 influential
Percentile%95.3
FWCI4.481.00 = world average
Scopus (SJR)Q3
WoS (JCR)Q4

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueMultidisciplinary Respiratory Medicine
  • Catalog match (ISSN)Multidisciplinary Respiratory Medicine
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)
  • Semantic Scholarcitation count (not merged with OpenAlex)

Abstract

OpenAlex English

BACKGROUND: To investigate whether 2 cardiac troponins [conventional troponin-T(cTnT) and high sensitive troponin-T(hsTnT)] combined with simplified pulmonary embolism severity index (sPESI), or either test alone are useful for predicting 30-day mortality and 6 months adverse outcomes in patients with normotensive pulmonary embolism(PE). METHODS: The prospective study included 121 consecutive patients with normotensive PE confirmed by computerized tomographic(CT) pulmonary angiography. The primary end point of the study was the 30-day all-cause mortality. The secondary end point included the 180-day all-cause mortality, the nonfatal symptomatic recurrent PE, or the nonfatal major bleeding. RESULTS: Overall, 16 (13.2%) out of 121 patients died during the first month of follow up. The predefined hsTnT cutoff value of 0.014 ng/mL combined with a sPESI ≥1 'point(s) were the most significant predictor for 30-day mortality [OR: 27.6 (95% CI: 3.5-217) in the univariate analysis. Alone, sPESI ≥1 point(s) had the highest negative predictive value for both 30-day all-cause mortality and 6-months adverse outcomes,100% and 91% respectively. CONCLUSIONS: The hsTnT assay combined with the sPESI may provide better predictive information than the cTnT assay for early death of PE patients. Low sPESI (0 points) may be used for identifying the outpatient treatment for PE patients and biomarker levels seem to be unnecessary for risk stratification in these patients.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

45citationsOpenAlex · cited_by_count (cache / database)

30 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

  1. 2021 Right ventricle assessment in patients with pulmonary embolism at low risk for death based on clinical models: an individual patient data meta-analysisCitations 88 · OpenAlex
  2. 2015 Predictors of early death in patients with acute pulmonary embolismCitations 47 · OpenAlex
  3. 2015 Predictors of early death in patients with acute pulmonary embolismCitations 47 · OpenAlex
  4. 2015 Predictors of early death in patients with acute pulmonary embolismCitations 47 · OpenAlex
  5. 2015 Predictors of early death in patients with acute pulmonary embolismCitations 47 · OpenAlex
  6. 2015 Predictors of early death in patients with acute pulmonary embolismCitations 47 · OpenAlex
  7. 2014 Prognostic role of the Simplified Pulmonary Embolism Severity Index and the Shock Index in pulmonary embolismCitations 19 · OpenAlex
  8. 2014 Prognostic Role Of The Simplified Pulmonary Embolism Severity Index And Shock Index In Pulmonary EmbolismCitations 19 · OpenAlex
  9. 2017 Classification Of High-risk With Cardiac Troponin And Shock Index In Normotensive Patients With Pulmonary EmbolismCitations 15 · OpenAlex
  10. 2014 Combination and comparison of two models in prognosis of pulmonary embolism: Results from TUrkey Pulmonary Embolism Group (TUPEG) studyCitations 14 · OpenAlex

Authors

6
  1. SAVAŞ SEDAT ÖZSU 1
  2. YASİN ABUL 2
  3. ASIM ÖREM KARADENİZ TEKNİK ÜNİVERSİTESİ 3
  4. FUNDA ÖZTUNA 4
  5. TEVFİK ÖZLÜ 5
  6. HÜSEYİN YAMAN KARADENİZ TEKNİK ÜNİVERSİTESİ 6